Rotigotine and arterial occlusive disease Patient Reports February 12, 2012

Rotigotine Side Effects Report #6121691-3
Rotigotine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2009. Male patient, weighting 183.9 lb, was diagnosed with parkinson's disease  and was treated with Rotigotine. After drug was administered, patient experienced the following side effects: arterial occlusive disease, shoulder arthroplasty, tremor. Rotigotine dosage: 2 MG QD, TRANSDERMAL. During the same period patient was treated with COZAAR, CELEBREX, ASPIRIN, ATENOLOL, FLOMAX, ZOCOR, SINEMET, ESIDRIX. Patient was hospitalized. Patient recovered.